UK announces £3.1 billion hospital development programme
This article was originally published in Clinica
The UK government has launched a £3.1 billion ($4.5 billion) hospital building and modernisation programme. Twenty-nine schemes have been approved with the aim of increasing the capacity and quality of healthcare under the National Health Service (NHS), as set out in the national plan in July 2000.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.